| Description |
1 online resource (xiii, 299 pages) : illustrations (some color) |
| Series |
Neuropsychiatric Symptoms of Neurological Disease, 2196-2898 |
|
Neuropsychiatric symptoms of neurological disease, 2196-2898
|
| Contents |
Depression, Apathy, Anhedonia, and Fatigue in Parkinson's Disease -- Mild Cognitive Impairment in Parkinson's Disease -- Parkinson's Disease Dementia -- Impulse Control Disorders -- Influence of Dietary Constituents on Motor and Non-Motor Symptoms in Parkinson's Disease -- Psychosis in Parkinson's Disease -- Neuropsychiatric Manifestations in Atypical Parkinsonian Syndromes -- Neuropsychiatric Disturbances in Dystonia -- Depression in Huntington's Disease -- Cognitive Impairment and Dementia (Mild or Major Neurocognitive Disorder) in Huntington's Disease -- Tics -- Wilson's Disease -- Ataxia |
|
Preface; Acknowledgements; Contents; Contributors; Chapter 1: Depression, Apathy, Anhedonia, and Fatigue in Parkinson's Disease; Depression in PD; Definition and Pathophysiology; Definition; Pathophysiology; Epidemiology; Assessment Tools; PD Nonmotor-Associated Features; Management; Apathy in PD; Definition and Pathophysiology; Definition; Pathophysiology; Epidemiology; Assessment Tools; PD Nonmotor-Associated Features; Management; Anhedonia in PD; Definition and Pathophysiology; Definition; Pathophysiology; Epidemiology; Assessment Tools; PD Nonmotor-Associated Features |
|
Management Fatigue in PD; Definition and Pathophysiology; Definition; Pathophysiology; Epidemiology; Assessment Tools; PD Nonmotor-Associated Features; Management; References; Chapter 2: Mild Cognitive Impairment in Parkinson's Disease; Introduction; Cognition in Parkinson's Disease; The Role of Dopamine in Cognitive Impairment in PD; The Role of Acetylcholine in Cognitive Impairment in PD; Parkinson's Disease Mild Cognitive Impairment: Definition and Clinical Implications; Neuropsychological Assessment of Cognitive Impairment in PD; Tools for Cognitive Assessment in PD |
|
Level 1 Tests; The Mini-Mental State Examination (MMSE); The Montreal Cognitive Assessment (MoCA); Mini-Mental Parkinson (MMP); PDD-Short Screen; Clinical Dementia Rating Scale (CDR); The Frontal Assessment Battery; Level 2 Tests; The Mattis Dementia Rating Scale; SCOPA-COG (Scales for Outcomes of Parkinson's Disease-Cognition); PANDA (Parkinson Neuropsychometric Dementia Assessment); PD-CRS (Parkinson's Disease-Cognitive Rating Scale); Cambridge Cognitive Assessment (CAMCOG); Recommendations for the Interpretation of Test Results; Tools for Functional Assessment in PD |
|
The Parkinson's Disease: Cognitive Functional Rating Scale (PD-CFRS); The Brief Penn Daily Activities Questionnaire (PDAQ); Management of Cognitive Impairment in PD; Effects of Dopaminergic Stimulation on Cognition; Effects of Cholinergic Stimulation on Cognition; Conclusion; References; Chapter 3: Parkinson's Disease Dementia; Introduction; Epidemiology and Risk Factors; Clinical Features; Cognitive Features; Behavioral Features; Motor, Autonomic, and Other Associated Features; Genetic Factors; Neuropathological and Biochemical Correlates of PD-D; Neuroimaging in PD-D |
|
Diagnosis of PD-D Management of Patients with PD-D; Non-pharmacological Management; Pharmacological Treatment; Cholinesterase Inhibitors; NMDA Antagonists; Dopaminergic Drugs; Pharmacological Treatment of Behavioral Symptoms; References; Chapter 4: Impulse Control Disorders; Introduction; Epidemiology; Pathophysiology; Medication Effects; The Role of Parkinson's Disease; Overdose Hypothesis; PD-Related Neuropathology; Dyskinesia; Apathy; Cognitive Deficits; Individual Susceptibility Factors; Age and Gender; Depression; Substance Use Disorders; Family History of Gambling |
| Summary |
This is an up-to-date, comprehensive review of the neuropsychiatry of patients with movement disorders, i.e. Parkinson's disease, Huntington's disease, dystonia and others, by active authorities in the field, with an emphasis on diagnostic and management issues. This book includes critical appraisal of the methodological aspects and limitations of the current research on the neuropsychiatry of movement disorders and on unanswered questions/controversies. Symptomatology and pharmacological aspects of management are discussed, to provide robust information on drug dosages, side effects and int |
| Analysis |
psychiatrie |
|
psychiatry |
|
neurologie |
|
neurology |
|
geneeskunde |
|
medicine |
|
volksgezondheid |
|
public health |
|
Medicine (General) |
|
Geneeskunde (algemeen) |
| Notes |
Includes index |
|
Online resource; title from PDF title page (SpringerLink, viewed October 23, 2014) |
| Subject |
Movement disorders.
|
|
Neuropsychiatry.
|
|
Movement Disorders
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Movement disorders
|
|
Neuropsychiatry
|
| Form |
Electronic book
|
| Author |
Reichmann, Heinz, 1953- editor.
|
| ISBN |
9783319095370 |
|
3319095374 |
|
3319095366 |
|
9783319095363 |
|
9783319095387 |
|
3319095382 |
|
9783319351766 |
|
3319351761 |
|
